Helus Pharma Inc. (HELP)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $10.91
- As of
Kresmion compiles this page from HELP's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Helus Pharma Inc. (HELP): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-10-27.
See the full HELP dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for HELP on one page. Preview it with sample data, then open it live with a free account.
Preview the HELP dossierActive events for HELP
- high13F: funds added
5 tracked funds increased HELP this 2026Q2, institutional consensus
- mediumEarnings below estimates
Q1-2027: Missed consensus by 27.0%, EPS $-0.9102 vs $-0.7167 estimate
- high13F: large increase
CITADEL ADVISORS LLC added +351% to HELP (2026Q2)
- high13F: large increase
CITADEL ADVISORS LLC added +2226% to HELP (2026Q2)
- high13F: large increase
Point72 Asset Management, L.P. added +441% to HELP (2026Q2)
FREE, NO ACCOUNT
Every event on HELP, as it fires
You are seeing 5 of 13 events recorded on HELP since 2026-06-09.
The five above landed across 3 days. The other 8 were recorded on 3 other days. 7 of the 13 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in HELP (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 23256X407 · 2026Q2 | $17.4M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 23256X407 · 2026Q2 | $4.1M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 23256X407 · 2026Q2 | $704K | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 23256X407 · 2026Q2 | $408K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, HELP
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
HELP against its peers
HELP's return on equity of -47.7% ranks in the 48th percentile of 19 Biotechnology sub-industry peers, fiscal periods ending between 2024-12-31 and 2025-12-31.
| Metric | HELP | Peer median | Percentile | n |
|---|---|---|---|---|
| Operating margin | n/a | -271.0% | n/a | 7 |
| Net margin | n/a | -237.9% | n/a | 7 |
| Return on equity | -47.7% | -45.8% | 48 | 19 |
Peers (19): GERN, ANNX, XOMA.D, ARDX, SANA, ANL, SGMT, IMMX, ACHV, PRME, PHAR, DSGN, NVCT, AURA, KURA, ABUS, BCAX, SLDB, CRVS. Left out: IAM (no annual filing), APMD (no annual filing), ATTO (no annual filing), ODTX (no annual filing), SLBT (no annual filing), OBX (no annual filing). Fiscal periods ending between 2024-12-31 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (HELP: 40-F), reported in CAD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow HELP on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to HELP for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.